Given the limitations that our obese and non-obese patient cohorts were small, and follow-up duration relatively short, our data suggest that epithelial CXCL1 expression and CXCR1-positive tumour stroma in obese patients may be associated with more aggressive disease features. The gene discussed is CXCR1; the disease is neoplasm.